Because groundbreaking science is most valuable when it can be translated into products that are available to Texans, a crucial component of CPRIT’s mission is to create and support infrastructure in Texas that accelerates the movement of new cancer drugs, diagnostics, and therapies from the laboratory to the patient. This process is called commercialization. CPRIT takes its commitment to commercialization efforts seriously, dedicating personnel and operational funding to major commercial initiatives like the creation of the Commercialization Review Council and the recruitment of a virtual management company.

Read more...

Recent Events Funding Opportunities 2017 Innovations Conference

Recent Events

September 19, 2018 – Early Translational Research Award (Academic Research) and SEED Award (Product Development) Funding Opportunities

CPRIT Academic Research and Product Development Research Programs held a webinar to introduce a revised Early Translational Research Award (ETRA) RFA and a new Seed (SEED) Award RFA.

Dr. James Willson, Chief Scientific Officer provided an overview of the revised ETRA RFA and CPRIT’s interest in “bridging the gap” between promising new discoveries achieved in the research laboratory and commercial development for a therapeutic, device, or diagnostic assay through activities including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario and preclinical toxicology and formulation to de-risk the development of lead compounds or devices.

Mike Lang, Chief Product Development Officer provided an overview of a new Seed Award mechanism for early-stage oncology startups. This mechanism is designed to target companies that may be a bit early in their development timeline to be competitive for CPRIT’s two existing Product Development Research awards: the Texas Company Award and the Company Relocation Award. The goal of the Seed Award is to assist startups in bridging the gap between translational research and product development, thus bringing disruptive cancer-fighting technologies to market.

Please access resources from the webinar below:

Slide Presentation

Early Translational Research Award (ETRA) FAQ

Seed Awards for Product Development Research FAQ

Current Product Development Funding Opportunities
For Fiscal Year 2018*

Please enable JavaScript to view this table.

* Dates are subject to change

View Complete Product Development Funding Opportunities Schedule

Conference Banner

CPRIT's conference brought together nearly 800 scientists, oncologists, bioscience industry leaders, advocates, entrepreneurs, and public health leaders from across Texas and the nation.

View Conference Session Schedule and Presentations

View Event Coverage

Stay Connected

Follow CPRIT on Twitter. Like us on Facebook. Sign-up for CPRIT’s newsletter.

See More 2017 Conference Coverage